Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Men and women react differently to opioids, with hormones potentially influencing these differences.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

American men are older, more obese, and have longer infertility than Canadian men.

Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

A thorough initial check-up is essential before sperm banking to ensure the best chance of preserving good quality sperm.

Finasteride reduces corpus cavernosum weight but doesn't affect erectile response in rats.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Resistance exercise can reduce muscle protein issues caused by finasteride.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

RU 58841 may treat acne, hair loss, and excessive hair growth.

Long-term anabolic steroid use can lead to heart and metabolic health issues.

Finasteride affects young male rats' brain function and behavior negatively.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

An 8-year-old boy's early puberty was caused by a rare hormone-secreting brain tumor, which was successfully treated with surgery.

Using LC-MS/MS for hormone measurement can prevent false high testosterone results and avoid unnecessary tests.

A 31-year-old woman was diagnosed with Complete Androgen Insensitivity Syndrome much later than usual, leading to a call for earlier detection and treatment guidelines.